Please use this identifier to cite or link to this item: http://hdl.handle.net/10884/1454
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMonachino, Michelle-
dc.contributor.authorMoreira, J. Paulo-
dc.date.accessioned2019-12-10T13:15:46Z-
dc.date.available2019-12-10T13:15:46Z-
dc.date.issued2016-
dc.identifier.citationMonachino, M.; Moreira, J. P. (2016). CSR: a catalyst for corporate contribution to global health governance? A case study from the pharmaceutical industry. Hygiea Internationalis: an Interdisciplinary Journal for the History of Public Health, Vol. 12(2), p. 73-91.pt_PT
dc.identifier.urihttp://hdl.handle.net/10884/1454-
dc.description.abstractOver the past twenty years international health and development agencies (WHO, 1997, 2005; UN, 2002; World Bank, 2002; WEF, 2011) have gradually advocated towards a participation of the private for-profit sector, and especially large multinational corporations (MNCs), in global population health promotion and disease prevention. Participation has been justified in terms of the socioeconomic agency of corporations in a globalized world, as well as connected to the positive and negative social, environmental and health externalities consequent to business manufacturing, distribution and marketing practices.pt_PT
dc.language.isoenpt_PT
dc.publisherHygiea Internationalis: an Interdisciplinary Journal for the History of Public Healthpt_PT
dc.rightsopenAccess-
dc.subjectPublic healthpt_PT
dc.subjectCorporate social responsabilitypt_PT
dc.subjectPharmaceutical industrypt_PT
dc.subjectHealth promotionpt_PT
dc.titleCSR: a catalyst for corporate contribution to global health governance? A case study from the pharmaceutical industrypt_PT
dc.typearticlept_PT
dc.rparesnaopt_PT
Appears in Collections:A CE/GS - Artigos

Files in This Item:
File Description SizeFormat 
Corporate social responsability.pdf103.42 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.